Phase I Trial of DAR-901

计划入组 59 人 · 首次发布于 2014 年 2 月 14 日

A Phase 2 Study of RTA 901 (BIIB143) in Participants With Diabetic Peripheral Neuropathic Pain

计划入组 209 人 · 首次发布于 2025 年 3 月 25 日

Study To Evaluate Long Term Treatment Effect Of Diapep277® In Patients Who Have Completed Study 901 And Study 910** (Extension To 901)

首次发布于 2011 年 1 月 21 日

NA-901

B-901

VG-901

University of Padua

Italy

Helsinn Birex Pharmaceuticals Ltd.

Switzerland

Betaliq, Inc.

United States

CheckMate 901: Nivolumab Plus Chemotherapy Improves Survival in Advanced Urothelial Carcinoma

InMed's INM-901 Shows Significant Anti-Inflammatory Activity in Alzheimer's Disease Preclinical Study

InMed's Alzheimer's Drug Candidate INM-901 Shows Favorable Bioavailability in Large Animal Studies